{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:30:24Z","timestamp":1765546224315},"reference-count":16,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T00:00:00Z","timestamp":1572307200000},"content-version":"vor","delay-in-days":788,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1093\/annonc\/mdx356","type":"journal-article","created":{"date-parts":[[2017,7,13]],"date-time":"2017-07-13T19:26:03Z","timestamp":1499973963000},"page":"2049-2050","source":"Crossref","is-referenced-by-count":5,"title":["Proton therapy in mediastinal Hodgkin lymphoma: moving from dosimetric prediction to clinical evidence"],"prefix":"10.1016","volume":"28","author":[{"given":"U.","family":"Ricardi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Dabaja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.C.","family":"Hodgson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdx356_bb0010","first-page":"4","article-title":"Chemotherapy alone versus chemotherapy plus radiotherapy for adults with early stage Hodgkin lymphoma","volume":"27","author":"Blank","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1093\/annonc\/mdx356_bb0015","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1200\/JCO.2002.08.021","article-title":"Long term survival and competing causes of death in patients with early stage Hodgkin\u2019s disease treated at age 50 or younger","volume":"20","author":"Ng","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdx356_bb0020","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/annonc\/mdt156","article-title":"Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma","volume":"8","author":"Maraldo","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdx356_bb0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijrobp.2016.10.004","article-title":"Secondary breast cancer risk by radiation volume in women with Hodgkin lymphoma","volume":"97","author":"Conway","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdx356_bb0030","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1002\/cncr.23081","article-title":"Individualized estimates of second cancer risk after contemporary radiation therapy for Hodgkin lymphoma","volume":"110","author":"Hodgson","year":"2007","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdx356_bb0035","doi-asserted-by":"crossref","first-page":"186.","DOI":"10.1186\/1748-717X-7-186","article-title":"Different IMRT solutions vs 3D-conformal radiotherapy in early stage Hodgkin\u2019s lymphoma","volume":"7","author":"Fiandra","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1093\/annonc\/mdx356_bb0040","doi-asserted-by":"crossref","first-page":"94.","DOI":"10.1186\/1748-717X-9-94","article-title":"Dosimetric advantage of a \u201cbuttefly\u201d technique for intensity-modulated radiation therapy for young female patients with mediastinal Hodgkin lymphoma","volume":"9","author":"Voong","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1093\/annonc\/mdx356_bb0045","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijrobp.2015.02.030","article-title":"Optimized volumetric modulated arc therapy versus 3D-CRT for early stage mediastinal Hodgkin lymphoma without axillary involvement: a comparison of second cancers and heart disease risk","volume":"92","author":"Filippi","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdx356_bb0050","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijrobp.2015.01.013","article-title":"Minimizing late effects for patients with mediatinal Hodgkin lymphoma: deep inspiration breath-hold, IMRT, or both?","volume":"92","author":"Aznar","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdx356_bb0055","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ijrobp.2011.12.034","article-title":"Effective dose reduction to cardiac structures using protons compared with 3D-CRT and IMRT in mediastinal Hodgkin lymphoma","volume":"84","author":"Hoppe","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdx356_bb0060","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1118\/1.594365","article-title":"Proton penetration and control in nonhomogeneous phantoms","volume":"4","author":"Wingate","year":"1977","journal-title":"Med Phys"},{"key":"10.1093\/annonc\/mdx356_bb0065","doi-asserted-by":"crossref","first-page":"R99","DOI":"10.1088\/0031-9155\/57\/11\/R99","article-title":"Range uncertainties in proton therapy and the role of Monte Carlo simulations","volume":"57","author":"Paganetti","year":"2012","journal-title":"Phys Med Biol"},{"key":"10.1093\/annonc\/mdx356_bb0070","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.ijrobp.2014.11.021","article-title":"Relating proton treatments to photon treatments via the relative biological effectiveness-should we revise current clinical practice?","volume":"91","author":"Paganetti","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1093\/annonc\/mdx356_bb0075","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1093\/annonc\/mdx287","article-title":"Consolidative proton therapy after chemotherapy for patients with Hodgkin lymphoma","volume":"28","author":"Hoppe","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdx356_bb0080","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijrobp.2015.02.008","article-title":"Expert radiation oncologist interpretations of involved-site radiation therapy guidelines in the management of Hodgkin lymphoma. Int","volume":"92","author":"Hoppe","year":"2015","journal-title":"J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1093\/annonc\/mdx356_bb0085","doi-asserted-by":"crossref","first-page":"djv008.","DOI":"10.1093\/jnci\/djv008","article-title":"of valvular heart disease after treatment for Hodgkin lymphoma","volume":"107","author":"Cutter","year":"2015","journal-title":"J Natl Cancer Inst"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341935269X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092375341935269X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/28\/9\/2049\/19710042\/mdx356.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T08:28:38Z","timestamp":1624696118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092375341935269X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":16,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S092375341935269X"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdx356","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]}}}